Publications

Journal Article
Research Support, Non-U.S. Gov't
Epublish 22 citations
Electronic publication date
October 21, 2021

View on Pubmed.gov 33963218 | View on doi.org 10.1038/s41598-...

Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461.

Search for publications in this journal Sci Rep - 11(1):9812

Abstract

CX-5461 is a G-quadruplex (G4) ligand currently in trials with initial indications of clinical activity in cancers with defects in homologous recombination repair. To identify more genetic defects that could sensitize tumors to CX-5461, we tested synthetic lethality for 480 DNA repair and genome maintenance genes to CX-5461, pyridostatin (PDS), a structurally unrelated G4-specific stabilizer, and BMH-21, which binds GC-rich DNA but not G4 structures. We identified multiple members of HRD, Fanconi Anemia pathways, and POLQ, a polymerase with a helicase domain important for G4 structure resolution. Significant synthetic lethality was observed with UBE2N and RNF168, key members of the DNA damage response associated ubiquitin signaling pathway. Loss-of-function of RNF168 and UBE2N resulted in significantly lower cell survival in the presence of CX-5461 and PDS but not BMH-21. RNF168 recruitment and histone ubiquitination increased with CX-5461 treatment, and nuclear ubiquitination response frequently co-localized with G4 structures. Pharmacological inhibition of UBE2N acted synergistically with CX-5461. In conclusion, we have uncovered novel genetic vulnerabilities to CX-5461 with potential significance for patient selection in future clinical trials.

References

EMBO J. 2011 Aug 26;30(19):4033-46

Nucleic Acids Res. 2006 Feb 02;34(3):880-92

Mol Biotechnol. 2013 Mar;53(3):308-14

Oncotarget. 2016 Sep 27;7(39):64471-64504

Cited by 22 citations (total)

Journal Article Review

G-Quadruplexes and Their Ligands: Biophysical Methods to Unravel G-Quadruplex/Ligand Interactions.

Electronic publication date August 29, 2021

Search for publications in this journal Pharmaceuticals (Basel)

Tiago Santos [...] Carla Cruz et al.

Progress in the design of G-quadruplex (G4) binding ligands relies on the availability of approaches that assess the binding mode...

Journal Article Review

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward.

Electronic publication date May 15, 2022

Search for publications in this journal Cancers (Basel)

Asimina Zisi [...] Mikael S Lindström et al.

Rapid growth and unrestrained proliferation is a hallmark of many cancers. To accomplish this, cancer cells re-wire and increase their...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances